−Removed: MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
+Added: MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF E QUITY SECURITIES
Market Information
Our common stock is traded on The Nasdaq Global Market under the symbol “QTRX.”
+Added: Holders of Record
As of February 26, 2024, there were approximately 19 stockholders of record of our common stock.
+Added: Dividends are declared at the discretion of our Board of Directors and depend on actual cash flow from operations, our financial condition, capital requirements, and any other factors our Board of Directors may consider relevant.
+Added: Since our inception, we have not declared or paid any dividends.
+Added: Securities Authorized for Issuance under Equity Compensation Plans
+Added: Refer to the section titled “Part III, Item 12.
+Added: Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” of this Annual Report on Form 10-K for information required by Item 201(d) of Regulation S-K.
Unregistered Sales of Securities
−Removed: There were no unregistered sales of equity securities during the fourth quarter ended December 31, 2022.
+Added: There were no unregistered sales of equity securities during the year ended December 31, 2023.
Issuer Purchases of Equity Securities
Not applicable.
+Added: Stock Performance Graph
+Added: The following graph compares the cumulative total shareholder returns over the past five years for our common stock, the NASDAQ Composite Index, and the NASDAQ Biotechnology Index, assuming $100 invested on December 31, 2018, and reinvestment of dividends, if paid:
Not applicable.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.